CalciMedica, Inc. — Form 8-K
Filed July 7, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Form 8-K filed 2026-07-07 reporting Item 5.02 event (director/officer departure or compensatory arrangement) with period of report 2026-07-02. Specific names, titles, dollar amounts, equity grants, and effective dates are not visible in the provided filing header/metadata; full document text required to extract concrete details.
Why this rating
Officer/director changes are routine disclosure. Without specifics (named executive, role, compensation magnitude, departure/hire), cannot assess materiality to $15.7M company.
Extracted items
See more from July 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.